Share >  
Share
Share on Tumblr

Natco Pharma Limited

News »

   latest by relevance
PATENTS OR PATIENTS?
May 09, 2012 at 16:10 | Source: Moneycontrol.com
By: Vikas Dandekar, PharmaAsia News
Cancer drug wars! Cipla slashes prices
May 04, 2012 at 13:45 | Source: CNBC-TV18
It's a drug war, but with a difference and it's been kicked off by Cipla. CNBC TV18's Archana Shukla reports that country's second largest drug firm has slashed prices of three of its key cancer drugs by more than half, making cancer medication costs come down by over 50%.
Cipla's price cut is strategic move: Expert
May 04, 2012 at 13:01 | Source: CNBC-TV18
Cipla's move to slash price of its cancer drug by almost 75% is a strong one, this is not only a humanitarian move, but is a strategic play as well, Vikas Dandekar of Pharmasianews.com told CNBC-TV18.
Bull's Eye: Buy Titan, Bajaj Finserv, Tata Coffee
Apr 28, 2012 at 14:35 | Source: Moneycontrol.com
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Exit from Natco Pharma, says Aashish Tater
Apr 27, 2012 at 19:01 | Source: CNBC-TV18
Aashish Tater, Head of Research, Fort Share Broking advice traders to exit from Natco Pharma.
Sensex stays flat; Sun Pharma, Cipla, SpiceJet most active
Apr 13, 2012 at 12:42 | Source: Moneycontrol.com
The BSE Sensex stayed moderately higher due to consistent buying interest in banks, oil & gas, infrastructure and FMCG stocks. However, sharp fall Infosys post weak guidance for Q1 and FY13 has limited the major upside of the market.

Videos »
Cipla's price cut is strategic move: Expert
Cancer drug wars! Cipla slashes prices
Bull's Eye: Buy Titan, Bajaj Finserv, Tata Coffee
Exit from Natco Pharma, says Aashish Tater
Stay away from Biocon: PN Vijay
more »

Photos »

  /  
News across the web »
Natco Pharma Q4 net dips 12% to Rs 12.6 crTotal income increased 33% to Rs 154 cr
Hyderabad-based drug maker Natco Pharma Limited has reported a 12.03% decline in net profit to Rs 12.65 crore for the quarter ended March 31, 2012, as against Rs 14.38 crore in the corresponding quart...
May 29, 2012 at 19:22 | Source: Business Standard
IPAB to hear Bayer's petition on August 21
The Intellectual Property Appellate Board (IPAB) in Chennai on Friday fixed August 21, 2012, for hearing the petition of the global pharmaceutical company, Bayer AG, against the compulsory licence (CL...
May 19, 2012 at 02:01 | Source: Business Standard
more »
Interact & exchange stock tips & market info »

MMB Messenger

Platinum Member

112824 Followers

Natco Pharma  

Natco Pharma Limited has informed the Exchange th...

1.31 PM May 29th

MMB Messenger

Platinum Member

112824 Followers

Natco Pharma  

Natco Pharma Limited has informed the Exchange re...

1.22 PM May 29th

MMB Messenger

Platinum Member

112824 Followers

Natco Pharma  

Natco Pharma Limited has submitted to the Exchang...

10.33 AM May 29th

Related News »
United States: Country Risk: Illustrated
In the matter of Natco Pharma Limited (Natco) and Bayer Corporation (Bayer), Natco applied for and was granted a compulsory license under Section 84(i) of the Patents Act, 1970. Under the patent law in India, a compulsory license is an involuntary contract ...
May 25, 2012 at 09:44 | Source: Mondaq
Search Results q4fy12
Natco Pharma Q4 net dips 12% to Rs 12.6 cr 29-MAY-12 Hyderabad-based drug maker Natco Pharma Limited has reported a 12.03% decline in net profit to Rs 12.65 crore for the quarter ended March 31, 2012, as against Rs 14.38 crore in the corresponding quarter ...
May 22, 2012 at 16:50 | Source: Business Standard

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window